Point72 Middle East Fze Guardant Health, Inc. Transaction History

Point72 Middle East Fze

  • $0
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$21.58 - $29.5 $1.02 Million - $1.4 Million
47,360 New
47,360 $1.28 Million
Q1 2023

May 15, 2023
BUY
$22.92 - $33.76 $491,427 - $723,848
21,441 Added 214.41%
31,441 $736,000
Q4 2022

Feb 14, 2023
BUY
$25.44 - $59.78 $254,400 - $597,800
10,000 New
10,000 $0

Others Institutions Holding GH

# of Institutions
323
Shares Held
127M
Call Options Held
844K
Put Options Held
2.38M
View Full List

About Guardant Health, Inc.

GH Quotes by TradingView
  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.75B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Point72 Middle East Fze Portfolio

Follow Point72 Middle East Fze and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Middle East Fze with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email